The Optical Coherence Tomography in Age-Related Macular Degeneration Study: The OCT in AMD Study
NCT ID: NCT00531141
Last Updated: 2009-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2007-05-31
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retinal Thickness Analysis Using Optical Coherence Tomography
NCT00797134
Non-invasive Optical Angiography in Age-related Macular Degeneration
NCT02521142
Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)
NCT00564291
High Resolution Optical Coherence Tomography
NCT05130385
Macular Thickness Measurements Using Retinal-thickness OCT
NCT03030729
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
examination twice by examiner 1
examination only
OCT performed twice
B
examination first by examiner 1 thereafter by examiner 2
examination only
OCT performed twice
C
examination first by examiner 2 thereafter by examiner 1
examination only
OCT performed twice
D
examination performed twice by examiner 2
examination only
OCT performed twice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
examination only
OCT performed twice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age related macular degeneration
Exclusion Criteria
* Visualization of the macula not possible (dens cataract, vitreous haemorrhage)
* Not consented patients
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ilse Krebs, MD
Role: PRINCIPAL_INVESTIGATOR
Rudolf Foundation Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Krebs I, Hagen S, Brannath W, Haas P, Womastek I, de Salvo G, Ansari-Shahrezaei S, Binder S. Repeatability and reproducibility of retinal thickness measurements by optical coherence tomography in age-related macular degeneration. Ophthalmology. 2010 Aug;117(8):1577-84. doi: 10.1016/j.ophtha.2010.04.032. Epub 2010 Jun 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK 07-078-VK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.